menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Scilex Highlights Ztlido® Data Versus Lidocaine 5% Patch

    GLOBENEWSWIRE

    Zydus gets USFDA nod for generic topical anaesthetic cream

    ECONOMICTIMES

    Enforcement Report - Week of December 4, 2024

    FDA

    Scilex Pharma Announces FDA Meeting for SP-103 Path Forward

    GLOBENEWSWIRE

    Scilex Announces Continuing Support From Endeavor

    GLOBENEWSWIRE

    Scilex Holding Receives NABP Drug Distributor Accreditation

    GLOBENEWSWIRE

    Scilex Announces Presentation At Rheumatology Conference

    GLOBENEWSWIRE

    Scilex To Present On ZTlido At PAINWeek Conference In Las Vegas

    GLOBENEWSWIRE

    Scilex Appoints Annu Navani To Board Of Directors

    GLOBENEWSWIRE

    Scilex Partners With ACEA To Expand ZTlido In Far East

    GLOBENEWSWIRE

    Aurobindo Pharma`s Generic Lidocaine Receives Approval in US

    FDA

    Enforcement Report - Week of June 5, 2024

    FDA

    Teikoku Announces Lidoderm® Approval In China

    PR NEWSWIRE

    Enforcement Report - Week of February 14, 2024

    FDA

    Scilex announces that ZTlido will be added as a preferred agent to PDL

    GLOBENEWSWIRE

    Scilex announces the addition of ZTlido as a preferred agent to the Medicaid PDL

    GLOBENEWSWIRE

    Scilex Holding Company Announces Issuance of New Patent in the U.S. for ZTlido

    GLOBENEWSWIRE

    Scilex Announces New Data From Deeper Skin Penetration Studies to Support SP-103

    GLOBENEWSWIRE

    Enforcement Report - Week of October 25, 2023

    FDA

    Enforcement Report - Week of October 11, 2023

    FDA

    Scilex Announces the Completion of SP-103 5.4%, Formulation of ZTlido, PII trial

    GLOBENEWSWIRE

    Scilex Holding Company Presented Oral and Poster Presentations on ZTlido

    GLOBENEWSWIRE

    Pfizer says supply of some drugs may be disrupted after NC tornado

    FINANCE YAHOO

    Enforcement Report - Week of June 7, 2023

    FDA

    Enforcement Report - Week of May 10, 2023

    FDA

    Scilex Holding Company Announces Complete Enrollment of a pH 2 Study SP-103

    GLOBENEWSWIRE

    Enforcement Report - Week of February 1, 2023

    FDA

    Enforcement Report - Week of January 25, 2023

    FDA

    Scilex Announces Expanding Coverage With One Of The Largest PBMs For ZTlido

    GLOBENEWSWIRE

    Scilex sues Apotex to block generic copy of key pain patch

    FIERCEPHARMA

    Enforcement Report - Week Of June 01, 2022

    FDA

    FDA confirms Paragraph IV Patent Litigation for Lidocaine.

    FDA

    Aleor receives US FDA final approval for Lidocaine and Prilocaine cream

    EXPRESS PHARMA

    Aleor Dermaceuticals Generic Lidocaine:Prilocaine Receives Approval in US

    FDA

    Enforcement Report - Week of March 30, 2022

    FDA

    Novitium Pharma`s Generic Lidocaine Hydrochloride Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of February 2, 2022

    FDA

    Enforcement Report - Week of November 17, 2021

    FDA

    A.Menarini soon to launch HA based dermal filler available with Lidocaine

    PHARMABIZ

    Enforcement Report - Week of September 8, 2021

    FDA

    Scilex Holding Announces Ztlido Managed Care Coverage for additional 33M Lives

    GLOBENEWSWIRE

    Enforcement Report - Week of April 21, 2021

    FDA

    Enforcement Report - Week of February 17, 2021

    FDA

    Rhodes Pharms`s Generic Lidocaine: Prilocaine Receives Approval In US

    FDA

    Amneal Pharmaceuticals Generic Lidocaine Receives Approval in US

    FDA

    Enforcement Report - Week of August 19, 2020

    FDA

    Enforcement Report - Week of June 3, 2020

    FDA

    HHS, Industry Partners Expand U.S.-Based Pharma Manufacturing for COVID-19

    HHS

    There Is a Lack of Evidence, Transparency About Ingredients to Support Use

    NATIONNALACADEMIES

    Vapogenix Reports positive Phase II Result of Topical Non-Opioid Pain Medication

    BUSINESSWIRE

    Sungen Pharma`s generic Lidocaine Receives Approval in US

    FDA

    Premier’s ProvideGx™ Program Partners with Amphastar

    BIOSPACE

    Enforcement Report - Week of September 25, 2019

    FDA

    Xospata leads latest CHMP recommendations

    PHARMATIMES

    EMA`s CHMP Recommends Three New Medicines

    RAPS

    KRS Global Biotechnology Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products

    FDA

    Enforcement Report - Week of August 14, 2019

    FDA

    Ridge Properties LLC DBA Pain Relief Naturally Issues Voluntary Nationwide Recall of PRE-TAT

    FDA

    SnugZ USA, Inc. Receives FDA Warning Letter

    FDA

    SnugZ USA, Inc Receives FDA Warning Letter

    FDA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.